Gaudium IVF and Women Health Limited has announced board approval for a variation in the utilization of Initial Public Offer (IPO) proceeds. The primary change involves the proposed variation of 6 cities/locations out of the 19 planned new IVF centres and a revision of their establishment schedule. This variation, subject to shareholder approval via postal ballot, aims to optimize the deployment of funds for the company’s growth strategy.
Board Approves IPO Fund Variation for IVF Center Expansion
Gaudium IVF and Women Health Limited has announced that its Board of Directors, during a meeting held on November 12, 2026, has approved a variation in the utilization of funds raised through its Initial Public Offer (IPO). This decision pertains to Object No. 1 of the IPO, which was initially focused on establishing 19 new IVF Centres.
Key Changes in IVF Center Rollout
The proposed variation includes two main adjustments:
- A change or substitution of 6 cities/locations out of the planned 19 centres.
- A revision to the schedule of establishment, with all 19 centres now slated to be operational by Fiscal 2029.
The total amount allocated for this object remains unchanged at ₹5,000.00 Lakhs. This strategic adjustment is subject to the approval of the Company’s Members through a Special Resolution via Postal Ballot.
Unaudited Financial Results and Other Approvals
In addition to the IPO fund utilization update, the Board also approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company also approved the appointment of Dr. Ravish Manchanda as National Head – Operations Expansion & Strategy, designating him as Senior Management Personnel (SMP).
Furthermore, an amendment to the Company’s Policy on Code of practices and procedures for fair disclosure of unpublished price sensitive information was approved.
Financial Highlights
The unaudited standalone financial results for the quarter ended September 30, 2026, show a profit after tax of ₹819.97 Lakhs, with total comprehensive income at ₹822.38 Lakhs. The standalone balance sheet as of September 30, 2026, indicates total assets of ₹18,419.97 Lakhs and total equity of ₹15,901.39 Lakhs.
The consolidated financial results for the same period report a profit after tax of ₹941.31 Lakhs, with total comprehensive income at ₹943.72 Lakhs. The consolidated balance sheet as of September 30, 2026, shows total assets of ₹20,042.46 Lakhs and total equity of ₹16,314.54 Lakhs.
Source: BSE
